MedPath
TGA Approval

Tezspire tezepelumab 210 mg in 1.91mL solution for Injection prefilled pen (432812)

432812

Tezspire tezepelumab 210 mg in 1.91mL solution for Injection prefilled pen

AstraZeneca Pty Ltd

March 24, 2025

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2025-CMI-01448-1

Product Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2025-PI-01449-1

Active Ingredients

tezepelumab

© Copyright 2025. All Rights Reserved by MedPath